Bone Marrow Allograft Rejection Mediated by a Novel Murine NK Receptor, NKG2I

Journal of Experimental Medicine

Volumn 199, Issue 1, 2004, Pages 137-143

  Koike, Junzo ^a   Wakao, Hiroshi ^b   Ishizuka, Yuko ^b   Sato, Taka Aki ^c   Hamaoki, Masaru ^c   Seino, Ken Ichiro ^b,d   Koseki, Haruhiko ^b   Nakayama, Toshinori ^a   Taniguchi, Masaru ^a,b  

^a CHIBA UNIVERSITY   (Japan)

^b INST OF PHYS AND CHEMICAL RESEARCH   (Japan)

^c YAMASA CORPORATION   (Japan)

^d JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

Activating receptor; C type lectin family; IFN ; NK cells; NKT cells

Indexed keywords

AMINO ACID; CD94 ANTIGEN; CELL RECEPTOR; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 2; LECTIN; LYSINE; MONOCLONAL ANTIBODY; NKG21 RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BONE MARROW TRANSPLANTATION; CELL MEDIATED CYTOTOXICITY; CONTROLLED STUDY; CROSS LINKING; FLOW CYTOMETRY; GRAFT REJECTION; MOLECULAR RECOGNITION; MOUSE; NATURAL KILLER CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FAMILY; RAT; SEQUENCE HOMOLOGY; T LYMPHOCYTE; TARGET CELL;

AMINO ACID SEQUENCE; ANIMALS; BONE MARROW TRANSPLANTATION; GENE LIBRARY; GRAFT REJECTION; KILLER CELLS, NATURAL; MICE; MICE, INBRED STRAINS; MICE, NUDE; MOLECULAR SEQUENCE DATA; RATS; RATS, INBRED F344; RECEPTORS, IMMUNOLOGIC; T-LYMPHOCYTES; TRANSPLANTATION, HOMOLOGOUS;

EID: 0346024085     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.20030851     Document Type: Article

References (29)

1. Murphy, W.J., V. Kumar, and M. Bennett. 1987. Rejection of bone marrow allografts by mice with severe combined immune deficiency (SCID). Evidence that natural killer cells can mediate the specificity of marrow graft rejection. J. Exp. Med. 165:1212-1217.
2. Trinchieri, G. 1989. Biology of natural killer cells. Adv. Immunol. 47:187-376.
3. Lanier, L.L. 1998. NK cell receptors. Annu. Rev. Immunol. 16:359-393.
4. Yokoyama, W.M. 1998. Natural killer cell receptors. Curr. Opin. Immunol. 10:298-305.
5. Colonna, M. 1997. Specificity and function of immunoglobulin superfamily NK cell inhibitory and stimulatory receptors. Immunol. Rev. 155:127-133.
6. Moretta, A., R. Biassoni, C. Bottino, D. Pende, M. Vitale, A. Poggi, M.C. Mingari, and L. Moretta. 1997. Major histocompatibility complex class I-specific receptors on human natural killer and T lymphocytes. Immunol. Rev. 155:105-117.
7. Raulet, D.H., W. Held, I. Correa, J.R. Dorfman, M.F. Wu, and L. Corral. 1997. Specificity, tolerance and developmental regulation of natural killer cells defined by expression of class I-specific Ly49 receptors. Immunol. Rev. 155:41-52.
8. Houchins, J.P., T. Yabe, C. McSherry, and F.H. Bach. 1991. DNA sequence analysis of NKG2, a family of related cDNA clones encoding type II integral membrane proteins on human natural killer cells. J. Exp. Med. 173:1017-1020.
9. Vance, R.E., D.M. Tanamachi, T. Hanke, and D.H. Raulet. 1997. Cloning of a mouse homolog of CD94 extends the family of C-type lectins on murine natural killer cells. Eur. J. Immunol. 27:3236-3241.
10. Glienke, J., Y. Sobanov, C. Brostjan, C. Steffens, C. Nguyen, H. Lehrach, E. Hofer, and F. Francis. 1998. The genomic organization of NKG2C, E, F, and D receptor genes in the human natural killer gene complex. Immunogenetics. 48:163-173.
11. Anderson, S.K., J.R. Ortaldo, and D.W. McVicar. 2001. The ever-expanding Ly49 gene family: repertoire and signaling. Immunol. Rev. 181:79-89.
12. Cerwenka, A., and L.L. Lanier. 2001. Ligands for natural killer cell receptors: redundancy or specificity. Immunol. Rev. 181:158-169.
13. Vilches, C., and P. Parham. 2002. KIR: diverse, rapidly evolving receptors of innate and adaptive immunity. Annu. Rev. Immunol. 20:217-251.
14. Toyama-Sorimachi, N., Y. Taguchi, H. Yagita, F. Kitamura, A. Kawasaki, S. Koyasu, and H. Karasuyama. 2001. Mouse CD94 participates in Qa-1-mediated self recognition by NK cells and delivers inhibitory signals independent of Ly-49. J. Immunol. 166:3771-3779.
15. Raziuddin, A., D.L. Longo, L. Mason, J.R. Ortaldo, M. Bennett, and W.J. Murphy. 1998. Differential effects of the rejection of bone marrow allografts by the depletion of activating versus inhibiting Ly-49 natural killer cell subsets. J. Immunol. 160:87-94.
16. Cui, J., T. Shin, T. Kawano, H. Sato, E. Kondo, I. Toura, Y. Kaneko, H. Koseki, M. Kanno, and M. Taniguchi. 1997. Requirement for Valpha14 NKT cells in IL-12-mediated rejection of tumors. Science. 278:1623-1626.
17. Boyington, J.C., A.N. Riaz, A. Patamawenu, J.E. Coligan, A.G. Brooks, and P.D. Sun. 1999. Structure of CD94 reveals a novel C-type lectin fold: implications for the NK cell-associated CD94/NKG2 receptors. Immunity. 10:75-82.
18. Wolan, D.W., L. Teyton, M.G. Rudolph, B. Villmow, S. Bauer, D.H. Busch, and I.A. Wilson. 2001. Crystal structure of the murine NK cell-activating receptor NKG2D at 1.95 A. Nat. Immunol. 2:248-254.
19. Moretta, A., C. Bottino, M. Vitale, D. Pende, C. Cantoni, M.C. Mingari, R. Biassoni, and L. Moretta. 2001. Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annu. Rev. Immunol. 19:197-223.
20. Lanier, L.L. 2001. On guard-activating NK cell receptors. Nat. Immunol. 2:23-27.
21. Vance, R.E., J.R. Kraft, J.D. Altman, P.E. Jensen, and D.H. Raulet. 1998. Mouse CD94/NKG2A is a natural killer cell receptor for the nonclassical major histocompatibility complex (MHC) class I molecule Qa-1(b). J. Exp. Med. 188: 1841-1848.
22. Vance, R.E., A.M. Jamieson, and D.H. Raulet. 1999. Recognition of the class Ib molecule Qa-1(b) by putative activating receptors CD94/NKG2C and CD94/NKG2E on mouse natural killer cells. J. Exp. Med. 190:1801-1812.
23. Diefenbach, A., A.M. Jamieson, S.D. Liu, N. Shastri, and D.H. Raulet. 2000. Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages. Nat. Immunol. 1:119-126.
24. Cerwenka, A., A.B. Bakker, T. McClanahan, J. Wagner, J. Wu, J.H. Phillips, and L.L. Lanier. 2000. Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice. Immunity. 12:721-727.
25. Carayannopoulos, L.N., O.V. Naidenko, D.H. Fremont, and W.M. Yokoyama. 2002. Cutting edge: murine UL16-binding protein-like transcript 1: a newly described transcript encoding a high-affinity ligand for murine NKG2D. J. Immunol. 169:4079-4083.
26. Olsson-Alheim, M.Y., M. Salcedo, H.G. Ljunggren, K. Karre, and C.L. Sentman. 1997. NK cell receptor calibration: effects of MHC class I induction on killing by Ly49Ahigh and Ly49Alow NK cells. J. Immunol. 159:3189-3194.
27. Ortaldo, J.R., A.T. Mason, R. Winkler-Pickett, A. Raziuddin, W.J. Murphy, and L.H. Mason. 1999. Ly-49 receptor expression and functional analysis in multiple mouse strains. J. Leukoc. Biol. 66:512-520.
28. Bakker, A.B., J. Wu, J.H. Phillips, and L.L. Lanier. 2000. NK cell activation: distinct stimulatory pathways counterbalancing inhibitory signals. Hum. Immunol. 61:18-27.
29. Tiberghien, P., D.L. Longo, J.W. Wine, W.G. Alvord, and C.W. Reynolds. 1990. Anti-asialo GM1 antiserum treatment of lethally irradiated recipients before bone marrow transplantation: evidence that recipient natural killer depletion enhances survival, engraftment, and hematopoietic recovery. Blood. 76:1419-1430.